SAM
ICPT

Senzar Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Senzar Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-61,900
Closed -$9.66M – 41
2014
Q4 		$9.66M Buy
+61,900
New +$11.4M 2.83% 15

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Senzar Asset Management's ICPT Position: Q1 2015 in Review

Senzar Asset Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2015, closing a stake of 61,900 shares — an estimated $9.66M sold.

Senzar Asset Management first reported a position in ICPT in Q4 2014 and held it in 1 quarter. The position peaked at $9.66M in Q4 2014. 200 funds tracked by Wall St. Rank hold ICPT as of Q1 2015.

  • Senzar Asset Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
  • Senzar Asset Management sold 61,900 Intercept Pharmaceuticals, Inc. shares in Q1 2015, an estimated $9.66M.
  • Senzar Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2014 and held it in 1 quarter.
  • Senzar Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $9.66M in Q4 2014.
  • 200 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2015.

Based on Senzar Asset Management's 13F filing for Q1 2015, filed 15 May 2015.